Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
03.01. | Procaps Group, S.A.: Procaps Group Receives Additional Delinquency Letter | 201 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
31.12.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
20.12.24 | Procaps Group announces newly appointed board members, CFO transition | 2 | Seeking Alpha | ||
20.12.24 | Procaps Group, S.A.: Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates | 197 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
PROCAPS GROUP Aktie jetzt für 0€ handeln | |||||
20.12.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
03.12.24 | Procaps announces financing, shareholders agreement and board updates | 3 | Seeking Alpha | ||
03.12.24 | Procaps Group, S.A.: Procaps Group Announces Financing, Shareholders Agreement and Board Updates | 126 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
29.11.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | - | SEC Filings | ||
29.11.24 | Pre-market Movers: Bolt Projects, Applied Therapeutics, Primega Group, Procaps Group, SKK Holdings | 611 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.25 A.M. ET).In the Green Bolt Projects Holdings, Inc. (BSLK) is up over 233%... ► Artikel lesen | |
16.11.24 | Procaps Group, S.A.: Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing | 211 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), announced today that, on November 13, 2024, the Company received... ► Artikel lesen | |
15.11.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
01.11.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
10.10.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 148 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
08.10.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
18.09.24 | Procaps secures forbearance agreements and shareholder funds | 7 | Investing.com | ||
18.09.24 | Procaps sichert Stillhalteabkommen und Aktionärsgelder | 3 | Investing.com Deutsch | ||
18.09.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
18.09.24 | Procaps Group, S.A.: Procaps Issues Shareholder Letter Update | 284 | GlobeNewswire (Europe) | MIAMI and BARRANQUILLA, Colombia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services... ► Artikel lesen | |
03.09.24 | Procaps Group, S.A. - 6-K, Report of foreign issuer | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 3,752 | +0,37 % | Aurora Cannabis Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
CANOPY GROWTH | 2,185 | +2,34 % | Trump jetzt am Drücker: Neue Hoffnungen für Tilray, Canopy & Co. oder droht der nächste Abverkauf? | © Foto: adobe.stock.comDer Amtsantritt Donald Trumps am gestrigen Montag schlug hohe Wellen. Seine Antrittsrede machte deutlich, dass sich Vieles ändern wird. Auch für den Cannabis-Sektor dürften es... ► Artikel lesen | |
TILRAY BRANDS | 1,110 | -1,60 % | Tilray Brands Has Diversified Its Business Through Alcohol, but Is the Stock a Better Buy Than It Was 5 Years Ago? | ||
TEVA | 21,100 | +0,48 % | Keros spikes as Teva deal takes effect; Cantor downgrades on trial setback | ||
VERTEX PHARMACEUTICALS | 409,55 | -0,29 % | HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws' | ||
ARZNEIWERK AG VIDA | 0,540 | +1,89 % | PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß §§ 114-117 WpHG
Berlin (pta/20.08.2024/15:00)... ► Artikel lesen | |
CRONOS GROUP | 1,870 | +0,16 % | Cronos-Aktie: Lohnt sich hier ein Kauf? | Die Aktie von Cronos ist wie die meisten Cannabiswerte in den vergangenen Monaten unter Druck geraten. Doch ist der kanadische Titel jetzt einen Blick für Anleger wert? Immerhin winken hier vergleichsweise... ► Artikel lesen | |
VIATRIS | 10,730 | -1,20 % | Viatris-Aktie: Kurs heute im Minus (10,8872 €) | Das Wertpapier von Viatris notiert am Mittwoch ein wenig leichter. Der jüngste Kurs betrug 11,20 US-Dollar. Für die Aktie von Viatris steht gegenwärtig ein Minus von 4,44 Prozent zu Buche. Das Papier... ► Artikel lesen | |
INCYTE | 70,18 | -0,48 % | Incyte And Syndax: FDA Approves Niktimvo 9 Mg And 22 Mg Vial Sizes | WASHINGTON (dpa-AFX) - Incyte (INCY) and Syndax Pharmaceuticals (SNDX) announced that the U.S. Food and Drug Administration has approved Niktimvo (axatilimab-csfr) in 9 mg and 22 mg vial sizes.... ► Artikel lesen | |
BAUSCH HEALTH | 7,199 | +0,49 % | Bausch Health Companies Inc.: Bausch Health Statement on Selection of XIFAXAN (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program | LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for... ► Artikel lesen | |
IONIS PHARMACEUTICALS | 32,240 | +2,81 % | Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) CEO Sells $1,091,310.35 in Stock | ||
CRESCO LABS | 0,850 | -1,22 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
ALNYLAM PHARMACEUTICALS | 249,20 | -1,97 % | (ALNY) - Analyzing Alnylam Pharmaceuticals' Short Interest | ||
NEKTAR THERAPEUTICS | 0,880 | +1,38 % | Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis | SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced the company has completed target enrollment in its REZOLVE-AD... ► Artikel lesen | |
ORAMED PHARMACEUTICALS | 2,185 | -1,27 % | Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025 |